Moderna Phase 3 Covid-19 vaccine trial to begin in two weeks

Moderna (MRNA +3.2%) will begin its Phase 3 trial of mRNA-1273 on 30K adult participants on July 27.

In the experimental arm, each participant will receive one injection of 100 microgram mRNA-1273 on Day 1 and on Day 29. There will also be a placebo arm. The study will take place across 87 locations.

Shares of Moderna are up more than 250% in the last six months, with the rally starting mid-March on hopes for a successful vaccine.

https://seekingalpha.com/news/3591067-moderna-phase-3-covidminus-19-vaccine-trial-to-begin-in-two-weeks